ZNTL Zentalis Pharmaceuticals2.08-0.32 (-13.3%)
Premarket Decliner
ZNTL Zentalis Pharmaceuticals2.400.000.0%
Premarket:1.58-0.82 (-34.2%)
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Globe NewswireWed, 29-Jan 7:00 AM
ZNTL Zentalis Pharmaceuticals2.27-0.03 (-1.3%)
ZNTL Zentalis Pharmaceuticals4.48+1.24 (+38.3%)
ZNTL Zentalis Pharmaceuticals15.94-0.44 (-2.7%)
ZNTL Zentalis Pharmaceuticals26.30+1.67 (+6.8%)